[Erythrapheresis in children with sickle cell disease, experience of a paediatric apheresis unit].

Érythraphérèses chez l’enfant drépanocytaire, expérience d’une unité d’aphérèse pédiatrique.

Journal

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
ISSN: 1953-8022
Titre abrégé: Transfus Clin Biol
Pays: France
ID NLM: 9423846

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 7 9 2021
medline: 3 11 2021
entrez: 6 9 2021
Statut: ppublish

Résumé

Erythrocyte exchanges on cell separators can be used in children with sickle cell disease and are effective in lowering the level of haemoglobin S. Of the 938 aphereses performed in 2020 in our unit, we observed a low rate of failure of procedures and few complications. Ninety-six percent of erythraphereses were performed in the context of chronic exchange programs, in more than 80% of cases for cerebral vasculopathy or after the occurrence of ischemic strokes. Less than 4% of the procedures were performed for specific indications (preparation for cholecystectomy most often). The vascular access is rarely an obstacle to the realisation of the apheresis. In case of insufficient venous capital, installing an arteriovenous fistula may be considered. Depending on the child's weight, haemoglobin level, and the severity of the sickle cell anaemia, precautions may be necessary when priming the procedure. Nurses experienced in paediatric apheresis and a good medical knowledge of sickle cell disease allowed us to use this technique from the age of 3years and the weight of 15kg.

Identifiants

pubmed: 34487854
pii: S1246-7820(21)00468-7
doi: 10.1016/j.tracli.2021.09.002
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

360-363

Informations de copyright

Copyright © 2021 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

E Lesprit (E)

Établissement français du sang, région Île-de-France, site Robert-Debré, unité de médecine transfusionnel et curative, 75019 Paris, France. Electronic address: Emmanuelle.lesprit@efs.sante.fr.

F Missud (F)

Assistance publique-Hôpitaux de Paris, hôpital Robert-Debré, centre de référence de la drépanocytose, 75019 Paris, France.

A Arnould (A)

Établissement français du sang, région Île-de-France, site Robert-Debré, unité de médecine transfusionnel et curative, 75019 Paris, France.

D Smaine (D)

Établissement français du sang, région Île-de-France, site Robert-Debré, unité de médecine transfusionnel et curative, 75019 Paris, France.

M Benkerrou (M)

Assistance publique-Hôpitaux de Paris, hôpital Robert-Debré, centre de référence de la drépanocytose, 75019 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH